TREK	B:C0754471
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
are	O
suppressed	O
in	O
patients	O
with	O
atrial	O
fibrillation	I:C0004238
and	O
heart	O
failure	I:C0018801
and	O
provide	O
therapeutic	O
targets	O
for	O
rhythm	O
control	O
.	O

TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
are	O
suppressed	O
in	O
patients	O
with	O
atrial	B:C0004238
fibrillation	I:C0004238
and	O
heart	O
failure	I:C0018801
and	O
provide	O
therapeutic	O
targets	O
for	O
rhythm	O
control	O
.	O

TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
are	O
suppressed	O
in	O
patients	O
with	O
atrial	O
fibrillation	I:C0004238
and	O
heart	B:C0018801
failure	I:C0018801
and	O
provide	O
therapeutic	O
targets	O
for	O
rhythm	O
control	O
.	O

Atrial	B:C0004238
fibrillation	I:C0004238
(	O
Atrial	O
fibrillation	I:C0004238
)	O
is	O
the	O
most	O
common	O
cardiac	O
arrhythmia	I:C0003811
.	O

Atrial	O
fibrillation	I:C0004238
(	O
Atrial	B:C0004238
fibrillation	I:C0004238
)	O
is	O
the	O
most	O
common	O
cardiac	O
arrhythmia	I:C0003811
.	O

Atrial	O
fibrillation	I:C0004238
(	O
Atrial	O
fibrillation	I:C0004238
)	O
is	O
the	O
most	O
common	O
cardiac	B:C0003811
arrhythmia	I:C0003811
.	O

Concomitant	B:C0018801
heart	I:C0018801
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
poses	O
a	O
particular	O
therapeutic	O
challenge	O
and	O
is	O
associated	O
with	O
prolonged	O
atrial	O
electrical	I:C0034954
refractoriness	I:C0034954
compared	O
with	O
non-failing	O
hearts	I:C0018787
.	O

Concomitant	O
heart	I:C0018801
failure	I:C0018801
(	O
heart	B:C0018801
failure	I:C0018801
)	O
poses	O
a	O
particular	O
therapeutic	O
challenge	O
and	O
is	O
associated	O
with	O
prolonged	O
atrial	O
electrical	I:C0034954
refractoriness	I:C0034954
compared	O
with	O
non-failing	O
hearts	I:C0018787
.	O

Concomitant	O
heart	I:C0018801
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
poses	O
a	O
particular	O
therapeutic	O
challenge	B:C1315011
and	O
is	O
associated	O
with	O
prolonged	O
atrial	O
electrical	I:C0034954
refractoriness	I:C0034954
compared	O
with	O
non-failing	O
hearts	I:C0018787
.	O

Concomitant	O
heart	I:C0018801
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
poses	O
a	O
particular	O
therapeutic	O
challenge	O
and	O
is	O
associated	O
with	O
prolonged	O
atrial	B:C0034954
electrical	I:C0034954
refractoriness	I:C0034954
compared	O
with	O
non-failing	O
hearts	I:C0018787
.	O

Concomitant	O
heart	I:C0018801
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
poses	O
a	O
particular	O
therapeutic	O
challenge	O
and	O
is	O
associated	O
with	O
prolonged	O
atrial	O
electrical	I:C0034954
refractoriness	I:C0034954
compared	O
with	O
non-failing	B:C0018787
hearts	I:C0018787
.	O

We	O
hypothesized	O
that	O
downregulation	B:C0013081
of	O
atrial	O
repolarizing	I:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	O
remodeling	I:C3658220
during	O
Atrial	O
fibrillation	I:C0004238
with	O
heart	O
failure	I:C0018801
,	O
and	O
that	O
TREK	O
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	O
fibrillation	I:C0004238
subset	O
.	O

We	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	B:C1371280
repolarizing	I:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	O
remodeling	I:C3658220
during	O
Atrial	O
fibrillation	I:C0004238
with	O
heart	O
failure	I:C0018801
,	O
and	O
that	O
TREK	O
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	O
fibrillation	I:C0004238
subset	O
.	O

We	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	O
repolarizing	I:C1371280
TREK	B:C0754471
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	O
remodeling	I:C3658220
during	O
Atrial	O
fibrillation	I:C0004238
with	O
heart	O
failure	I:C0018801
,	O
and	O
that	O
TREK	O
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	O
fibrillation	I:C0004238
subset	O
.	O

We	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	O
repolarizing	I:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	B:C3658220
remodeling	I:C3658220
during	O
Atrial	O
fibrillation	I:C0004238
with	O
heart	O
failure	I:C0018801
,	O
and	O
that	O
TREK	O
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	O
fibrillation	I:C0004238
subset	O
.	O

We	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	O
repolarizing	I:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	O
remodeling	I:C3658220
during	O
Atrial	B:C0004238
fibrillation	I:C0004238
with	O
heart	O
failure	I:C0018801
,	O
and	O
that	O
TREK	O
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	O
fibrillation	I:C0004238
subset	O
.	O

We	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	O
repolarizing	I:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	O
remodeling	I:C3658220
during	O
Atrial	O
fibrillation	I:C0004238
with	O
heart	B:C0018801
failure	I:C0018801
,	O
and	O
that	O
TREK	O
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	O
fibrillation	I:C0004238
subset	O
.	O

We	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	O
repolarizing	I:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	O
remodeling	I:C3658220
during	O
Atrial	O
fibrillation	I:C0004238
with	O
heart	O
failure	I:C0018801
,	O
and	O
that	O
TREK	B:C1517499
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	O
fibrillation	I:C0004238
subset	O
.	O

We	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	O
repolarizing	I:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	O
remodeling	I:C3658220
during	O
Atrial	O
fibrillation	I:C0004238
with	O
heart	O
failure	I:C0018801
,	O
and	O
that	O
TREK	O
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	B:C1882115
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	O
fibrillation	I:C0004238
subset	O
.	O

We	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	O
repolarizing	I:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	O
remodeling	I:C3658220
during	O
Atrial	O
fibrillation	I:C0004238
with	O
heart	O
failure	I:C0018801
,	O
and	O
that	O
TREK	O
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	O
of	O
atrial	B:C0428938
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	O
fibrillation	I:C0004238
subset	O
.	O

We	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	O
repolarizing	I:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	O
remodeling	I:C3658220
during	O
Atrial	O
fibrillation	I:C0004238
with	O
heart	O
failure	I:C0018801
,	O
and	O
that	O
TREK	O
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	B:C0004238
fibrillation	I:C0004238
subset	O
.	O

We	O
hypothesized	O
that	O
downregulation	O
of	O
atrial	O
repolarizing	I:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
(	I:C0754471
K2P2.1	I:C0754471
)	I:C0754471
K	I:C0754471
(+	I:C0754471
)	I:C0754471
channels	I:C0754471
contributes	O
to	O
electrical	O
remodeling	I:C3658220
during	O
Atrial	O
fibrillation	I:C0004238
with	O
heart	O
failure	I:C0018801
,	O
and	O
that	O
TREK	O
-	I:C1517499
1	I:C1517499
gene	I:C1517499
transfer	I:C1517499
would	O
provide	O
rhythm	O
control	O
via	O
normalization	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
in	O
this	O
Atrial	O
fibrillation	I:C0004238
subset	B:C2986480
.	O

In	O
patients	O
with	O
chronic	B:C0694539
AF	I:C0694539
and	O
heart	O
failure	I:C0018801
,	O
atrial	O
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
mRNA	O
levels	O
were	O
reduced	O
by	O
82	O
%	O
(	O
left	O
atrium	I:C0225860
)	O
and	O
81	O
%	O
(	O
right	O
atrium	I:C0225844
)	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
(	O
sinus	O
rhythm	I:C0232201
)	O
subjects	O
.	O

In	O
patients	O
with	O
chronic	O
AF	I:C0694539
and	O
heart	B:C0018801
failure	I:C0018801
,	O
atrial	O
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
mRNA	O
levels	O
were	O
reduced	O
by	O
82	O
%	O
(	O
left	O
atrium	I:C0225860
)	O
and	O
81	O
%	O
(	O
right	O
atrium	I:C0225844
)	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
(	O
sinus	O
rhythm	I:C0232201
)	O
subjects	O
.	O

In	O
patients	O
with	O
chronic	O
AF	I:C0694539
and	O
heart	O
failure	I:C0018801
,	O
atrial	B:C0754471
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
mRNA	O
levels	O
were	O
reduced	O
by	O
82	O
%	O
(	O
left	O
atrium	I:C0225860
)	O
and	O
81	O
%	O
(	O
right	O
atrium	I:C0225844
)	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
(	O
sinus	O
rhythm	I:C0232201
)	O
subjects	O
.	O

In	O
patients	O
with	O
chronic	O
AF	I:C0694539
and	O
heart	O
failure	I:C0018801
,	O
atrial	O
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
mRNA	B:C0035696
levels	O
were	O
reduced	O
by	O
82	O
%	O
(	O
left	O
atrium	I:C0225860
)	O
and	O
81	O
%	O
(	O
right	O
atrium	I:C0225844
)	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
(	O
sinus	O
rhythm	I:C0232201
)	O
subjects	O
.	O

In	O
patients	O
with	O
chronic	O
AF	I:C0694539
and	O
heart	O
failure	I:C0018801
,	O
atrial	O
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
mRNA	O
levels	O
were	O
reduced	O
by	O
82	O
%	O
(	O
left	B:C0225860
atrium	I:C0225860
)	O
and	O
81	O
%	O
(	O
right	O
atrium	I:C0225844
)	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
(	O
sinus	O
rhythm	I:C0232201
)	O
subjects	O
.	O

In	O
patients	O
with	O
chronic	O
AF	I:C0694539
and	O
heart	O
failure	I:C0018801
,	O
atrial	O
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
mRNA	O
levels	O
were	O
reduced	O
by	O
82	O
%	O
(	O
left	O
atrium	I:C0225860
)	O
and	O
81	O
%	O
(	O
right	B:C0225844
atrium	I:C0225844
)	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
(	O
sinus	O
rhythm	I:C0232201
)	O
subjects	O
.	O

In	O
patients	O
with	O
chronic	O
AF	I:C0694539
and	O
heart	O
failure	I:C0018801
,	O
atrial	O
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
mRNA	O
levels	O
were	O
reduced	O
by	O
82	O
%	O
(	O
left	O
atrium	I:C0225860
)	O
and	O
81	O
%	O
(	O
right	O
atrium	I:C0225844
)	O
compared	O
with	O
sinus	B:C0232201
rhythm	I:C0232201
(	O
sinus	O
rhythm	I:C0232201
)	O
subjects	O
.	O

In	O
patients	O
with	O
chronic	O
AF	I:C0694539
and	O
heart	O
failure	I:C0018801
,	O
atrial	O
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
mRNA	O
levels	O
were	O
reduced	O
by	O
82	O
%	O
(	O
left	O
atrium	I:C0225860
)	O
and	O
81	O
%	O
(	O
right	O
atrium	I:C0225844
)	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
(	O
sinus	B:C0232201
rhythm	I:C0232201
)	O
subjects	O
.	O

In	O
patients	O
with	O
chronic	O
AF	I:C0694539
and	O
heart	O
failure	I:C0018801
,	O
atrial	O
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
mRNA	O
levels	O
were	O
reduced	O
by	O
82	O
%	O
(	O
left	O
atrium	I:C0225860
)	O
and	O
81	O
%	O
(	O
right	O
atrium	I:C0225844
)	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
(	O
sinus	O
rhythm	I:C0232201
)	O
subjects	B:C0080105
.	O

Human	B:C0086418
findings	O
were	O
recapitulated	O
in	O
a	O
porcine	O
model	O
of	O
atrial	O
tachypacing	I:C0004238
-	I:C0004238
induced	I:C0004238
AF	I:C0004238
and	O
reduced	O
left	O
ventricular	I:C0080310
function	I:C0080310
.	O

Human	O
findings	B:C0243095
were	O
recapitulated	O
in	O
a	O
porcine	O
model	O
of	O
atrial	O
tachypacing	I:C0004238
-	I:C0004238
induced	I:C0004238
AF	I:C0004238
and	O
reduced	O
left	O
ventricular	I:C0080310
function	I:C0080310
.	O

Human	O
findings	O
were	O
recapitulated	O
in	O
a	O
porcine	O
model	O
of	O
atrial	B:C0004238
tachypacing	I:C0004238
-	I:C0004238
induced	I:C0004238
AF	I:C0004238
and	O
reduced	O
left	O
ventricular	I:C0080310
function	I:C0080310
.	O

Human	O
findings	O
were	O
recapitulated	O
in	O
a	O
porcine	O
model	O
of	O
atrial	O
tachypacing	I:C0004238
-	I:C0004238
induced	I:C0004238
AF	I:C0004238
and	O
reduced	O
left	B:C0080310
ventricular	I:C0080310
function	I:C0080310
.	O

TREK	B:C0754471
-	I:C0754471
1	I:C0754471
mRNA	O
(	O
-	O
66	O
%	O
)	O
and	O
protein	O
(	O
-	O
61	O
%	O
)	O
was	O
suppressed	O
in	O
Atrial	O
fibrillation	I:C0004238
animals	O
at	O
14	O
-	O
day	O
follow	O
-	O
up	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
controls	O
.	O

TREK	O
-	I:C0754471
1	I:C0754471
mRNA	B:C0035696
(	O
-	O
66	O
%	O
)	O
and	O
protein	O
(	O
-	O
61	O
%	O
)	O
was	O
suppressed	O
in	O
Atrial	O
fibrillation	I:C0004238
animals	O
at	O
14	O
-	O
day	O
follow	O
-	O
up	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
controls	O
.	O

TREK	O
-	I:C0754471
1	I:C0754471
mRNA	O
(	O
-	O
66	O
%	O
)	O
and	O
protein	B:C0754471
(	O
-	O
61	O
%	O
)	O
was	O
suppressed	O
in	O
Atrial	O
fibrillation	I:C0004238
animals	O
at	O
14	O
-	O
day	O
follow	O
-	O
up	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
controls	O
.	O

TREK	O
-	I:C0754471
1	I:C0754471
mRNA	O
(	O
-	O
66	O
%	O
)	O
and	O
protein	O
(	O
-	O
61	O
%	O
)	O
was	O
suppressed	O
in	O
Atrial	B:C0004238
fibrillation	I:C0004238
animals	O
at	O
14	O
-	O
day	O
follow	O
-	O
up	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
controls	O
.	O

TREK	O
-	I:C0754471
1	I:C0754471
mRNA	O
(	O
-	O
66	O
%	O
)	O
and	O
protein	O
(	O
-	O
61	O
%	O
)	O
was	O
suppressed	O
in	O
Atrial	O
fibrillation	I:C0004238
animals	B:C0003062
at	O
14	O
-	O
day	O
follow	O
-	O
up	O
compared	O
with	O
sinus	O
rhythm	I:C0232201
controls	O
.	O

TREK	O
-	I:C0754471
1	I:C0754471
mRNA	O
(	O
-	O
66	O
%	O
)	O
and	O
protein	O
(	O
-	O
61	O
%	O
)	O
was	O
suppressed	O
in	O
Atrial	O
fibrillation	I:C0004238
animals	O
at	O
14	O
-	O
day	O
follow	O
-	O
up	O
compared	O
with	O
sinus	B:C0232201
rhythm	I:C0232201
controls	O
.	O

Downregulation	B:C0013081
of	O
repolarizing	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
was	O
associated	O
with	O
prolongation	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
versus	O
baseline	O
conditions	O
,	O
consistent	O
with	O
prior	O
observations	O
in	O
humans	O
with	O
heart	O
failure	I:C0018801
.	O

Downregulation	O
of	O
repolarizing	B:C1371280
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
was	O
associated	O
with	O
prolongation	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
versus	O
baseline	O
conditions	O
,	O
consistent	O
with	O
prior	O
observations	O
in	O
humans	O
with	O
heart	O
failure	I:C0018801
.	O

Downregulation	O
of	O
repolarizing	O
TREK	B:C0754471
-	I:C0754471
1	I:C0754471
channels	I:C0754471
was	O
associated	O
with	O
prolongation	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
versus	O
baseline	O
conditions	O
,	O
consistent	O
with	O
prior	O
observations	O
in	O
humans	O
with	O
heart	O
failure	I:C0018801
.	O

Downregulation	O
of	O
repolarizing	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
was	O
associated	O
with	O
prolongation	O
of	O
atrial	B:C0428938
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
versus	O
baseline	O
conditions	O
,	O
consistent	O
with	O
prior	O
observations	O
in	O
humans	O
with	O
heart	O
failure	I:C0018801
.	O

Downregulation	O
of	O
repolarizing	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
was	O
associated	O
with	O
prolongation	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
versus	O
baseline	O
conditions	O
,	O
consistent	O
with	O
prior	O
observations	B:C0302523
in	O
humans	O
with	O
heart	O
failure	I:C0018801
.	O

Downregulation	O
of	O
repolarizing	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
was	O
associated	O
with	O
prolongation	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
versus	O
baseline	O
conditions	O
,	O
consistent	O
with	O
prior	O
observations	O
in	O
humans	B:C0086418
with	O
heart	O
failure	I:C0018801
.	O

Downregulation	O
of	O
repolarizing	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
was	O
associated	O
with	O
prolongation	O
of	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
versus	O
baseline	O
conditions	O
,	O
consistent	O
with	O
prior	O
observations	O
in	O
humans	O
with	O
heart	B:C0018801
failure	I:C0018801
.	O

In	O
a	O
preclinical	O
therapeutic	O
approach	O
,	O
pigs	B:C0039005
were	O
randomized	O
to	O
either	O
atrial	O
Ad	I:C0017296
-	I:C0017296
TREK	I:C0017296
-	I:C0017296
1	I:C0017296
gene	I:C0017296
therapy	I:C0017296
or	O
sham	O
treatment	I:C0032042
.	O

In	O
a	O
preclinical	O
therapeutic	O
approach	O
,	O
pigs	O
were	O
randomized	B:C0034656
to	O
either	O
atrial	O
Ad	I:C0017296
-	I:C0017296
TREK	I:C0017296
-	I:C0017296
1	I:C0017296
gene	I:C0017296
therapy	I:C0017296
or	O
sham	O
treatment	I:C0032042
.	O

In	O
a	O
preclinical	O
therapeutic	O
approach	O
,	O
pigs	O
were	O
randomized	O
to	O
either	O
atrial	B:C0017296
Ad	I:C0017296
-	I:C0017296
TREK	I:C0017296
-	I:C0017296
1	I:C0017296
gene	I:C0017296
therapy	I:C0017296
or	O
sham	O
treatment	I:C0032042
.	O

In	O
a	O
preclinical	O
therapeutic	O
approach	O
,	O
pigs	O
were	O
randomized	O
to	O
either	O
atrial	O
Ad	I:C0017296
-	I:C0017296
TREK	I:C0017296
-	I:C0017296
1	I:C0017296
gene	I:C0017296
therapy	I:C0017296
or	O
sham	B:C0032042
treatment	I:C0032042
.	O

Gene	B:C1517499
transfer	I:C1517499
effectively	O
increased	O
TREK	O
-	I:C0754471
1	I:C0754471
protein	I:C0754471
levels	O
and	O
attenuated	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
period	I:C0428938
prolongation	O
in	O
the	O
porcine	O
AF	O
model	O
.	O

Gene	O
transfer	I:C1517499
effectively	O
increased	O
TREK	B:C0754471
-	I:C0754471
1	I:C0754471
protein	I:C0754471
levels	O
and	O
attenuated	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
period	I:C0428938
prolongation	O
in	O
the	O
porcine	O
AF	O
model	O
.	O

Gene	O
transfer	I:C1517499
effectively	O
increased	O
TREK	O
-	I:C0754471
1	I:C0754471
protein	I:C0754471
levels	O
and	O
attenuated	O
atrial	B:C0428938
effective	I:C0428938
refractory	I:C0428938
period	I:C0428938
prolongation	O
in	O
the	O
porcine	O
AF	O
model	O
.	O

Ad	B:C0754471
-	I:C0754471
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
increased	O
the	O
sinus	O
rhythm	I:C0232201
prevalence	O
to	O
62	O
%	O
during	O
follow	O
-	O
up	O
in	O
Atrial	O
fibrillation	I:C0004238
animals	O
,	O
compared	O
to	O
35	O
%	O
in	O
the	O
untreated	O
Atrial	O
fibrillation	I:C0004238
group	O
.	O

Ad	O
-	I:C0754471
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
increased	O
the	O
sinus	B:C0232201
rhythm	I:C0232201
prevalence	O
to	O
62	O
%	O
during	O
follow	O
-	O
up	O
in	O
Atrial	O
fibrillation	I:C0004238
animals	O
,	O
compared	O
to	O
35	O
%	O
in	O
the	O
untreated	O
Atrial	O
fibrillation	I:C0004238
group	O
.	O

Ad	O
-	I:C0754471
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
increased	O
the	O
sinus	O
rhythm	I:C0232201
prevalence	O
to	O
62	O
%	O
during	O
follow	O
-	O
up	O
in	O
Atrial	B:C0004238
fibrillation	I:C0004238
animals	O
,	O
compared	O
to	O
35	O
%	O
in	O
the	O
untreated	O
Atrial	O
fibrillation	I:C0004238
group	O
.	O

Ad	O
-	I:C0754471
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
increased	O
the	O
sinus	O
rhythm	I:C0232201
prevalence	O
to	O
62	O
%	O
during	O
follow	O
-	O
up	O
in	O
Atrial	O
fibrillation	I:C0004238
animals	B:C0003062
,	O
compared	O
to	O
35	O
%	O
in	O
the	O
untreated	O
Atrial	O
fibrillation	I:C0004238
group	O
.	O

Ad	O
-	I:C0754471
TREK	I:C0754471
-	I:C0754471
1	I:C0754471
increased	O
the	O
sinus	O
rhythm	I:C0232201
prevalence	O
to	O
62	O
%	O
during	O
follow	O
-	O
up	O
in	O
Atrial	O
fibrillation	I:C0004238
animals	O
,	O
compared	O
to	O
35	O
%	O
in	O
the	O
untreated	O
Atrial	B:C0004238
fibrillation	I:C0004238
group	O
.	O

In	O
conclusion	O
,	O
TREK	B:C0754471
-	I:C0754471
1	I:C0754471
downregulation	O
and	O
rhythm	O
control	O
by	O
Ad-	O
TREK	I:C1517499
-	I:C1517499
1	I:C1517499
transfer	I:C1517499
suggest	O
mechanistic	O
and	I:C0087111
potential	I:C0087111
therapeutic	I:C0087111
significance	O
of	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
in	O
a	O
subgroup	O
of	O
Atrial	O
fibrillation	I:C0004238
patients	O
with	O
heart	O
failure	I:C0018801
and	O
prolonged	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
.	O

In	O
conclusion	O
,	O
TREK	O
-	I:C0754471
1	I:C0754471
downregulation	B:C0013081
and	O
rhythm	O
control	O
by	O
Ad-	O
TREK	I:C1517499
-	I:C1517499
1	I:C1517499
transfer	I:C1517499
suggest	O
mechanistic	O
and	I:C0087111
potential	I:C0087111
therapeutic	I:C0087111
significance	O
of	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
in	O
a	O
subgroup	O
of	O
Atrial	O
fibrillation	I:C0004238
patients	O
with	O
heart	O
failure	I:C0018801
and	O
prolonged	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
.	O

In	O
conclusion	O
,	O
TREK	O
-	I:C0754471
1	I:C0754471
downregulation	O
and	O
rhythm	O
control	O
by	O
Ad-	B:C1517499
TREK	I:C1517499
-	I:C1517499
1	I:C1517499
transfer	I:C1517499
suggest	O
mechanistic	O
and	I:C0087111
potential	I:C0087111
therapeutic	I:C0087111
significance	O
of	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
in	O
a	O
subgroup	O
of	O
Atrial	O
fibrillation	I:C0004238
patients	O
with	O
heart	O
failure	I:C0018801
and	O
prolonged	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
.	O

In	O
conclusion	O
,	O
TREK	O
-	I:C0754471
1	I:C0754471
downregulation	O
and	O
rhythm	O
control	O
by	O
Ad-	O
TREK	I:C1517499
-	I:C1517499
1	I:C1517499
transfer	I:C1517499
suggest	O
mechanistic	B:C0087111
and	I:C0087111
potential	I:C0087111
therapeutic	I:C0087111
significance	O
of	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
in	O
a	O
subgroup	O
of	O
Atrial	O
fibrillation	I:C0004238
patients	O
with	O
heart	O
failure	I:C0018801
and	O
prolonged	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
.	O

In	O
conclusion	O
,	O
TREK	O
-	I:C0754471
1	I:C0754471
downregulation	O
and	O
rhythm	O
control	O
by	O
Ad-	O
TREK	I:C1517499
-	I:C1517499
1	I:C1517499
transfer	I:C1517499
suggest	O
mechanistic	O
and	I:C0087111
potential	I:C0087111
therapeutic	I:C0087111
significance	O
of	O
TREK	B:C0754471
-	I:C0754471
1	I:C0754471
channels	I:C0754471
in	O
a	O
subgroup	O
of	O
Atrial	O
fibrillation	I:C0004238
patients	O
with	O
heart	O
failure	I:C0018801
and	O
prolonged	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
.	O

In	O
conclusion	O
,	O
TREK	O
-	I:C0754471
1	I:C0754471
downregulation	O
and	O
rhythm	O
control	O
by	O
Ad-	O
TREK	I:C1517499
-	I:C1517499
1	I:C1517499
transfer	I:C1517499
suggest	O
mechanistic	O
and	I:C0087111
potential	I:C0087111
therapeutic	I:C0087111
significance	O
of	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
in	O
a	O
subgroup	B:C1515021
of	O
Atrial	O
fibrillation	I:C0004238
patients	O
with	O
heart	O
failure	I:C0018801
and	O
prolonged	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
.	O

In	O
conclusion	O
,	O
TREK	O
-	I:C0754471
1	I:C0754471
downregulation	O
and	O
rhythm	O
control	O
by	O
Ad-	O
TREK	I:C1517499
-	I:C1517499
1	I:C1517499
transfer	I:C1517499
suggest	O
mechanistic	O
and	I:C0087111
potential	I:C0087111
therapeutic	I:C0087111
significance	O
of	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
in	O
a	O
subgroup	O
of	O
Atrial	B:C0004238
fibrillation	I:C0004238
patients	O
with	O
heart	O
failure	I:C0018801
and	O
prolonged	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
.	O

In	O
conclusion	O
,	O
TREK	O
-	I:C0754471
1	I:C0754471
downregulation	O
and	O
rhythm	O
control	O
by	O
Ad-	O
TREK	I:C1517499
-	I:C1517499
1	I:C1517499
transfer	I:C1517499
suggest	O
mechanistic	O
and	I:C0087111
potential	I:C0087111
therapeutic	I:C0087111
significance	O
of	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
in	O
a	O
subgroup	O
of	O
Atrial	O
fibrillation	I:C0004238
patients	O
with	O
heart	B:C0018801
failure	I:C0018801
and	O
prolonged	O
atrial	O
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
.	O

In	O
conclusion	O
,	O
TREK	O
-	I:C0754471
1	I:C0754471
downregulation	O
and	O
rhythm	O
control	O
by	O
Ad-	O
TREK	I:C1517499
-	I:C1517499
1	I:C1517499
transfer	I:C1517499
suggest	O
mechanistic	O
and	I:C0087111
potential	I:C0087111
therapeutic	I:C0087111
significance	O
of	O
TREK	O
-	I:C0754471
1	I:C0754471
channels	I:C0754471
in	O
a	O
subgroup	O
of	O
Atrial	O
fibrillation	I:C0004238
patients	O
with	O
heart	O
failure	I:C0018801
and	O
prolonged	O
atrial	B:C0428938
effective	I:C0428938
refractory	I:C0428938
periods	I:C0428938
.	O

Functional	O
correction	O
of	O
ionic	O
remodeling	O
through	O
TREK	B:C0017296
-	I:C0017296
1	I:C0017296
gene	I:C0017296
therapy	I:C0017296
represents	O
a	O
novel	O
paradigm	O
to	O
optimize	O
and	O
specify	O
Atrial	O
fibrillation	I:C0004238
management	O
.	O

Functional	O
correction	O
of	O
ionic	O
remodeling	O
through	O
TREK	O
-	I:C0017296
1	I:C0017296
gene	I:C0017296
therapy	I:C0017296
represents	O
a	O
novel	O
paradigm	O
to	O
optimize	O
and	O
specify	O
Atrial	B:C0004238
fibrillation	I:C0004238
management	O
.	O

